Abstract: The invention provides compounds capable of treating against hepatitis infections, particularly hepatitis B viral infections. Compounds of the invention are nucleic acid-based and preferably comprise 2, 3, 4, 5 or 6 nucleoside units.
Type:
Grant
Filed:
May 15, 2002
Date of Patent:
April 19, 2005
Assignee:
Migenix Inc.
Inventors:
Radhakrishnan P. Iyer, Yi Jin, Arlene Roland, Wenqiang Zhou
© 2024 Justia
